Schadendorf, D., Ugurel, S., & Figl, A. (2006). Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: A phase II DeCOG/ADO study. Annals of oncology, 17(10), . https://doi.org/10.1093/annonc/mdl148
Chicago Style (17th ed.) CitationSchadendorf, Dirk, Selma Ugurel, and Adina Figl. "Dose-intensified Bi-weekly Temozolomide in Patients with Asymptomatic Brain Metastases from Malignant Melanoma: A Phase II DeCOG/ADO Study." Annals of Oncology 17, no. 10 (2006). https://doi.org/10.1093/annonc/mdl148.
MLA (9th ed.) CitationSchadendorf, Dirk, et al. "Dose-intensified Bi-weekly Temozolomide in Patients with Asymptomatic Brain Metastases from Malignant Melanoma: A Phase II DeCOG/ADO Study." Annals of Oncology, vol. 17, no. 10, 2006, https://doi.org/10.1093/annonc/mdl148.